Guidelines
Cross-source consensus on Guidelines from 1 sources and 4 claims.
1 sources · 4 claims
Uses
Risks & contraindications
Background
Highlighted claims
- The 2022 MHRA safety alert recommended B12 testing in metformin-treated people with symptoms suggestive of deficiency. — Vitamin B12 deficiency in long-term metformin use and clinician awareness: a scoping review
- The 2022 MHRA alert also recommended checking B12 levels during annual review bloods for metformin-treated patients with risk factors, especially long-term users. — Vitamin B12 deficiency in long-term metformin use and clinician awareness: a scoping review
- Several guidelines recognise long-term metformin use as an established risk factor for vitamin B12 deficiency. — Vitamin B12 deficiency in long-term metformin use and clinician awareness: a scoping review
- Before 2022, the UK lacked official guidance specifically for management or monitoring of metformin-associated B12 deficiency. — Vitamin B12 deficiency in long-term metformin use and clinician awareness: a scoping review